- Global Pharma News & Resources

Press Releases - 2021-09-20

Date Title Company
20-Sep-2021 STRIDE Data Show Translarna™ Delays Loss of Ambulation by More Than Five Years in Boys with Nonsense Mutation Duchenne Muscular Dystrophy PTC Therapeutics Inc.
20-Sep-2021 Biotium Debuts Novel Fluorescent Dyes that Push Emission Further into the Infrared Spectrum Biotium
20-Sep-2021 GSK receives CHMP positive opinions recommending approval of Nucala (mepolizumab) in three additional eosinophil-driven diseases GSK
20-Sep-2021 M1 Kliniken AG continues growth course M1 Kliniken AG
20-Sep-2021 Welsh Minister of Economy opens CatSci’s New Material Science Laboratory CatSci Ltd
20-Sep-2021 Sales of Blood Collection Tubes for Liquid Biopsy to Soar at 6% CAGR Through 2029; Opportunities Abound in Genetic Diagnostics, Says Fact.MR MARKITWIRED Latest Market Reports
20-Sep-2021 Artificial Limbs Market to Expand at a Healthy CAGR of 6% through 2025 MARKITWIRED Latest Market Reports
20-Sep-2021 Gonorrhea Therapeutics Market is Estimated to Register a CAGR of ~4 through 2029 MARKITWIRED Latest Market Reports
20-Sep-2021 North America Region Remains Lucrative for Dyslipidemia Therapeutics Market, Says Fact.MR MARKITWIRED Latest Market Reports
20-Sep-2021 Rapid Oral Fluid Screening Devices Market Growth Uphold by Rising Focus to Combat Drug-Impaired Driving, Says Fact.MR MARKITWIRED Latest Market Reports
20-Sep-2021 Omnicell to launch innovative new solution at this year’s Clinical Pharmacy Congress Omnicell
20-Sep-2021 Santhera Secures CHF 45 Million in Funding and Announces Preliminary First Half-Year 2021 Financial Results Santhera Pharmaceuticals
20-Sep-2021 ESMO late-breaking data show Libtayo® (cemiplimab) and chemotherapy first-line treatment combination significantly improved overall survival in patients with advanced NSCLC Sanofi
20-Sep-2021 Takara Bio Europe AB and Boston IVF Fertility Center Announce Partnership to Enable the Derivation of Clinical-grade hES cell lines for Cell Therapy Applications Takara Bio Europe
20-Sep-2021 Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with Erdafitinib in Combination with Cetrelimab, a PD-1 Inhibitor The Janssen Pharmaceutical Companies of Johnson & Johnson
20-Sep-2021 Cellbox Solutions Establishes Subsidiary in the USA B3C newswire
20-Sep-2021 NEMA Research Inc. Named to Short-List of Citeline Awards for 2021 Nominated for Excellence in Innovation and Response to COVID-19 Newswire
20-Sep-2021 Leukocytoclastic Vasculitis Market Poised to Garner Maximum Revenues during 2021-2031, States Fact.MR MARKITWIRED Latest Market Reports
20-Sep-2021 E-commerce to be Fastest Growing Sales Channel for Finasteride Market, States Fact.MR MARKITWIRED Latest Market Reports